APA (7th ed.) Citation

Hertzberg, S. N., Moe, M. C., Jørstad, Ø. K., Petrovski, B. É., Burger, E., & Petrovski, G. (2022). Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema. Acta Ophthalmologica (1755375X), 100(8), e1630. https://doi.org/10.1111/aos.15151

Chicago Style (17th ed.) Citation

Hertzberg, Silvia NW, Morten Carstens Moe, Øystein Kalsnes Jørstad, Beáta Éva Petrovski, Emily Burger, and Goran Petrovski. "Healthcare Expenditure of Intravitreal Anti‐vascular Endothelial Growth Factor Inhibitors Compared with Dexamethasone Implant for Diabetic Macular Oedema." Acta Ophthalmologica (1755375X) 100, no. 8 (2022): e1630. https://doi.org/10.1111/aos.15151.

MLA (9th ed.) Citation

Hertzberg, Silvia NW, et al. "Healthcare Expenditure of Intravitreal Anti‐vascular Endothelial Growth Factor Inhibitors Compared with Dexamethasone Implant for Diabetic Macular Oedema." Acta Ophthalmologica (1755375X), vol. 100, no. 8, 2022, p. e1630, https://doi.org/10.1111/aos.15151.